TEVA PHARMACEUTICAL INDUSTRIES LIMITED Supplier Finance Program Obligation
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Supplier Finance Program Obligation of $257.00 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:SupplierFinanceProgramObligation · last filed 2026-07-29
- 2026-06-30: Supplier Finance Program Obligation $257.00M.
- 2026-03-31: Supplier Finance Program Obligation $251.00M.
- 2025-12-31: Supplier Finance Program Obligation $225.00M.
- 2025-09-30: Supplier Finance Program Obligation $171.00M.
| Period end | Supplier Finance Program Obligation | Supplier Finance Program Obligation as first filed |
|---|---|---|
| 2026-06-30 | $257.00M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $251.00M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $225.00M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $171.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $196.00M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $189.00M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $158.00M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $163.00M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $131.00M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $99.00M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $108.00M 10-K · filed 2025-02-05 | |
| 2023-09-30 | $85.00M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $84.00M 10-Q · filed 2023-08-02 | |
| 2022-12-31 | $108.00M 10-Q · filed 2024-05-08 | $34.00M 10-Q · filed 2023-08-02 |